Saccharomyces cerevisiae engineering bacteria and application thereof in fraxetin production

By introducing specific gene elements into Saccharomyces cerevisiae and optimizing fermentation conditions, the problems of high production cost and low yield of fraxin have been solved, achieving efficient high-value utilization of lignin with the highest yield, thus promoting resource recycling and industrial production.

CN119020394APending Publication Date: 2024-11-26TIANJIN UNIV SYNTHETIC BIOLOGY FRONTIER RES INST
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411311085.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-19
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

Existing technologies have high production costs and low purity of fraxin, making it difficult to achieve industrial application. Furthermore, the heterologous expression of key enzymes in lignin biotransformation by Saccharomyces cerevisiae is not effective, resulting in low yield.

Method used

Using Saccharomyces cerevisiae as the chassis, Pc4CL, AtF6′H1, AtS8H and AtCOSY gene elements were introduced. Through synthetic biology and metabolic engineering methods, a biotransformation pathway from lignin to fraxinerin was constructed. Fermentation conditions were optimized, and corn straw alkali pretreatment solution was used as the fermentation substrate to enhance the expression and reaction of key enzymes.

Benefits of technology

This study achieved highly efficient bioconversion of fraxinus, with the highest yield reported to date. It reduced production costs, decreased dependence on expensive carbon sources, promoted resource recycling, simplified the process, and improved conversion efficiency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005050727550000051
    Figure BDA0005050727550000051
  • Figure BDA0005050727550000061
    Figure BDA0005050727550000061
  • Figure BDA0005050727550000062
    Figure BDA0005050727550000062
Patent Text Reader

Abstract

The invention relates to the technical field of biology, in particular to saccharomyces cerevisiae engineering bacteria and application thereof in fraxetin production. According to the method disclosed by the invention, saccharomyces cerevisiae is selected as a chassis, COSY and S8H from Arabidopsis thaliana are introduced by using methods of synthetic biology, metabolic engineering, fermentation engineering and the like, and bioconversion from ferulic acid and lignin hydrolysate to fraxetin is realized. A key gene is found through pathway gene overexpression, a speed limiting step is optimized through multi-copy integration, the yield is improved through fermentation condition optimization, and the biological conversion process of generating fraxetin from lignin is completed by combining with sodium hydroxide alkaline pretreatment of corn straw.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of biotechnology, in particular to an engineering bacterium of saccharomyces cerevisiae and its application in the production of quercetin. Background Art

[0002] Lignin is a cross-linked heteropolymer based on aromatic compounds, accounting for about 15% to 40%, which can provide aromatic benzene ring structure and is a renewable resource with abundant reserves in nature. Improving the bioconversion and utilization of lignin is a hot topic in current research. Through synthetic biology and metabolic engineering strategies, lignin metabolic conversion routes are constructed in model strains such as Escherichia coli, Saccharomyces cerevisiae and Corynebacterium glutamicum, thereby converting lignin and its derived aromatic molecules in artificial cell factories to synthesize many chemicals, which has certain driving potential and application prospects for the high-value utilization of lignin.

[0003] Fraxetin (7,8-dihydroxy-6-methoxycoumarin, Fraxetin), also known as Fraxin, has a variety of biological activities and pharmacological effects (drug action mechanisms) confirmed by researchers or in clinical experiments in recent years. Combined with the existing research, Fraxetin may involve multiple mechanisms, such as antibacterial, anticancer, antioxidant, pro-apoptotic, relieving inflammatory response, neurological effects and protection, and has potential application prospects. As one of the important components of traditional Chinese medicine Fraxinus, Fraxetin is mainly derived from the bark and leaves of Fraxinus chinensis. Its abundance in nature is low and difficult to purify, which greatly limits its industrial production and application. At present, the main means of obtaining coumarin compounds represented by Fraxinus chinensis is extraction and purification from plants or chemical synthesis, but the extraction process and chemical synthesis method are very complicated and the purity of the obtained chemical products is not high. With the growing market demand for it, traditional extraction or chemical synthesis from plants is now considered to have high production costs, insufficient economic efficiency, and is unsustainable. In line with the development of green economy, using synthetic biology to construct microbial cell factories is a promising strategy for large-scale and economical production of quercetin. Synthetic biology has brought new opportunities for the production of this type of important biologically active finished products.

[0004] Previous studies have shown that F6'H1 does not use ferulic acid as a substrate, but ferulic acid coenzyme A, so 4CL is very necessary in the metabolic pathway. F6'H1 can ortho-hydroxylate ferulic acid coenzyme A and then spontaneously isomerize and lactonize to form scopoletin. Lin et al. co-expressed 4CL and F6'H1 in Escherichia coli, and used ferulic acid to synthesize scopoletin, a precursor of quercetin, with a yield of 27.8 mg / L. Yang et al. fused F6'H1 with GTS and co-expressed it with 4CL in Escherichia coli, and fermented it at the shake flask level using ferulic acid as a substrate, synthesizing 79.5 mg / L of quercetin precursor scopoletin. According to previous reports, coumarin synthase (COSY) has been demonstrated to be the key enzyme in the biosynthesis of coumarin, and scopoletin 8-hydroxylase (S8H) can catalyze the synthesis of scopoletin from scopoletin and is also crucial in its metabolic pathway.

[0005] Saccharomyces cerevisiae is generally considered to be a strain with a high biosafety factor. As a model eukaryote, it has mature genetic manipulation tools and gene manipulation methods. In addition, Saccharomyces cerevisiae also shows a certain degree of high tolerance to different industrial conditions. At present, the design and construction of some lignin bioconversion routes have been preliminarily completed in Saccharomyces cerevisiae, and further construction of new Saccharomyces cerevisiae cell factories will provide a new way to achieve high-value utilization of more components in biomass. Therefore, Saccharomyces cerevisiae will become a new and relatively easy-to-study platform microorganism for bioconversion of lignin to produce a variety of aromatic compounds, further realizing the high-value utilization of lignin. Zhao et al. found that ferulic acid can be synthesized into 74 μg / L quercetin by the catalysis of 4-coumarate CoA ligase (4CL) and feruloyl-CoA 6'-hydroxylase (F6'H1) in Saccharomyces cerevisiae, but the yield is very low. In the same year, ferulic acid was used to synthesize quercetin in Escherichia coli through the catalysis of 4CL, F6'H1 and S8H, with a yield of 6.93 mg / L. The primary problem faced by the synthesis of quercetin using Saccharomyces cerevisiae as a chassis strain may be the heterologous expression effect of key enzymes in the pathway, and the problem that foreign proteins need to be translated, folded, and function in other organisms or non-natural environments. This metabolic process involves modifications on the benzene ring, such as the hydroxylation reaction of the benzene ring, the catalytic activity of the hydroxylase, the compatibility of the genes that perform the corresponding functions with the new chassis, and the adaptability of the microbial strain to the substrate. Summary of the invention

[0006] In view of this, the present invention provides an engineered strain of Saccharomyces cerevisiae and its application in the production of quercetin. Saccharomyces cerevisiae is selected as the chassis, and synthetic biology, metabolic engineering, fermentation engineering and other methods are used to achieve the bioconversion of ferulic acid and lignin hydrolyzate to quercetin, providing a feasible strategy for green conversion for the high-value utilization of lignin. The high-value utilization of lignin is an important way to achieve large-scale production of industrial biorefining and increase the green economy of biomanufacturing. The present invention will promote the high-value conversion of lignin.

[0007] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0008] The present invention provides an application of a gene element combination in the preparation of fraxinusin, wherein the gene element combination comprises a Pc4CL gene derived from Petroselinum crispum, an AtF6′H1 gene derived from Arabidopsis thaliana, an AtS8H gene derived from Arabidopsis thaliana, and an AtCOSY gene derived from Arabidopsis thaliana;

[0009] Wherein, the sequence of the AtCOSY gene may be SEQ ID NO: 1;

[0010] The sequence of the AtS8H gene may be SEQ ID NO:2.

[0011] In some specific embodiments of the present invention, the above application comprises integrating the gene element combination into Saccharomyces cerevisiae to prepare fraxinusin.

[0012] In some specific embodiments of the present invention, the genotype of the Saccharomyces cerevisiae used above is BY4742, HO::his3_T TDH3 -P TDH3 -AtF6′H1-(GGGGS)4-Pc4CL-T CYC1 .

[0013] In some specific embodiments of the present invention, the brewer's yeast used above is yZCH21 described in Engineering budding yeast for the production of coumarins from lignin (DOI: 10.1016 / j.bej.2020.107634).

[0014] The present invention also provides an expression vector having the gene element combination in the above application.

[0015] The present invention also provides an expression vector combination, which has the gene element combination in the above application.

[0016] In some specific embodiments of the present invention, the above-mentioned expression vector combination comprises at least two and at most four expression vectors, each expression vector having at least one of the gene elements selected from the group consisting of Pc4CL gene, AtF6′H1 gene, AtS8H gene and AtCOSY gene, and each gene element exists in only one copy in the expression vector combination;

[0017] Wherein, the sequence of the AtCOSY gene may be SEQ ID NO: 1;

[0018] The sequence of the AtS8H gene may be SEQ ID NO:2.

[0019] In some specific embodiments of the present invention, the above-mentioned expression vector combination includes at least two expression vectors, each expression vector has at least one of the gene elements selected from the group consisting of Pc4CL gene, AtF6′H1 gene, AtS8H gene and AtCOSY gene, and each gene element may exist in multiple copies in the expression vector combination.

[0020] In some specific embodiments of the present invention, the above-mentioned expression vector combination includes expression vector 1, expression vector 2, expression vector 3 and expression vector 4;

[0021] The expression vector 1 has a promoter, a Pc4CL gene and a terminator;

[0022] The expression vector 2 has a promoter, an AtF6′H1 gene and a terminator;

[0023] The expression vector 3 has a promoter, an AtS8H gene and a terminator;

[0024] The expression vector 4 has a promoter, an AtCOSY gene and a terminator;

[0025] The promoter is selected from P TEF1 , P TDH3 ;

[0026] The terminator is selected from T CYC1 、T TDH3 、T PDC1 .

[0027] In some specific embodiments of the present invention, the above-mentioned expression vector or expression vector combination further comprises a homology arm;

[0028] The homology arm may be at least one of YORWdelta17, YERCdelta8 or YOLCdelta1.

[0029] In some specific embodiments of the present invention, the above-mentioned expression vector combination includes expression vector 1, expression vector 2, expression vector 3 and expression vector 4;

[0030] The expression vector 1 has an upstream homology arm, a promoter, a Pc4CL gene, a terminator and a downstream homology arm;

[0031] The expression vector 2 has an upstream homology arm, a promoter, an AtF6′H1 gene, a terminator and a downstream homology arm;

[0032] The expression vector 3 has an upstream homology arm, a promoter, an AtS8H gene, a terminator and a downstream homology arm;

[0033] The expression vector 4 has an upstream homology arm, a promoter, an AtCOSY gene, a terminator and a downstream homology arm;

[0034] The promoter is selected from P TEF1 , P TDH3 ;

[0035] The terminator is selected from T CYC1 、T TDH3 、T PDC1 .

[0036] In some specific embodiments of the present invention, the above-mentioned expression vector combination includes expression vector 1, expression vector 2, expression vector 3 and expression vector 4;

[0037] The expression vector 1 has an upstream homology arm, a promoter, a Pc4CL gene, a terminator and a downstream homology arm;

[0038] The expression vector 2 has an upstream homology arm, a promoter, an AtF6′H1 gene, a terminator and a downstream homology arm;

[0039] The expression vector 3 has an upstream homology arm, a promoter, an AtS8H gene, a terminator and a downstream homology arm;

[0040] The expression vector 4 has an upstream homology arm, a promoter, an AtCOSY gene, a terminator and a downstream homology arm;

[0041] The upstream homology arm or the downstream homology arm can be independently selected from YORWdelta17, YERCdelta8 or YOLCdelta1;

[0042] The promoter is selected from P TEF1 , P TDH3 ;

[0043] The terminator is selected from T CYC1 、T TDH3 、T PDC1 .

[0044] In some specific embodiments of the present invention, the above-mentioned expression vector or expression vector combination further has a marker gene, and the marker gene can be at least one of LEU2, URA3, and HIS3.

[0045] The present invention also provides a genetically engineered bacterium having the gene element combination, the expression vector or the expression vector combination in the above application.

[0046] In some specific embodiments of the present invention, the above-mentioned genetically engineered bacteria are obtained by the following transformations:

[0047] The AtS8H gene expression cassette and the AtCOSY gene expression cassette were integrated into the YORWdelta17 site of the genome of the chassis;

[0048] The chassis has an AtF6′H1 gene and a Pc4CL gene expression cassette;

[0049] Wherein, the sequence of the AtCOSY gene may be SEQ ID NO: 1;

[0050] The sequence of the AtS8H gene may be SEQ ID NO:2.

[0051] In some specific embodiments of the present invention, the above-mentioned genetically engineered bacteria are obtained by the following transformations:

[0052] The AtS8H gene expression cassette and the AtCOSY gene expression cassette were integrated into the YORWdelta17 site of the genome of the chassis;

[0053] The AtS8H gene expression cassette was integrated into the genomic YERCdelta8 site of the chassis;

[0054] The chassis has the AtF6'H1 gene and the Pc4CL gene expression cassette.

[0055] In some specific embodiments of the present invention, the above-mentioned genetically engineered bacteria are obtained by the following transformations:

[0056] The AtS8H gene expression cassette and the AtCOSY gene expression cassette were integrated into the YORWdelta17 site of the genome of the chassis;

[0057] The AtS8H gene expression cassette was integrated into the genomic YERCdelta8 site of the chassis;

[0058] The AtCOSY gene expression cassette was integrated into the genomic YOLCdelta1 site of the chassis;

[0059] The chassis has the AtF6'H1 gene and the Pc4CL gene expression cassette.

[0060] In some specific embodiments of the present invention, the chassis of the genetically engineered bacteria is Saccharomyces cerevisiae.

[0061] In some specific embodiments of the present invention, the chassis of the genetically engineered bacteria is Saccharomyces cerevisiae, the genotype is BY4742, HO::his3_T TDH3 -P TDH3 -AtF6′H1-(GGGGS)4-Pc4CL-T CYC1 .

[0062] In some specific embodiments of the present invention, the chassis of the above-mentioned genetically engineered bacteria is yZCH21 described in Engineering budding yeast for the production of coumarins from lignin (DOI: 10.1016 / j.bej.2020.107634).

[0063] The present invention also provides the use of any of the following in the preparation of quercetin:

[0064] (i) the above-mentioned expression vector; or

[0065] (ii) the above expression vector combination; or

[0066] (iii) the above-mentioned genetically engineered bacteria.

[0067] The present invention also provides a method for preparing frasquercetin, which is prepared based on any of the following:

[0068] (i) the above-mentioned expression vector; or

[0069] (ii) the above expression vector combination; or

[0070] (iii) the above-mentioned genetically engineered bacteria.

[0071] In some specific embodiments of the present invention, the above preparation method comprises obtaining fraxinusin by fermentation of the genetically engineered bacteria according to claim 5 or 6, wherein the fermentation conditions are: inoculation initial OD 600 is 0.4, 0.5 or 0.6, the temperature is 27°C, 28°C or 29°C, the speed is 210rpm, 215rpm, 220rpm, 225rpm or 230rpm, and the time is 24h, 48h, 60h, 72h, 84h, 96h or 108h.

[0072] In some specific embodiments of the present invention, the preparation method comprises obtaining fraxinusin by fermentation with the genetically engineered bacteria according to claim 5 or 6, wherein the fermentation uses corn straw alkali pretreated stock solution as a fermentation substrate;

[0073] The preparation method of the corn straw alkali pretreatment stock solution comprises: mixing corn straw particles with a particle size of 20 to 80 meshes with a sodium hydroxide solution at a solid-liquid ratio of 1:8, 1:9 or 1:10, reacting at 130° C. for 30 minutes, filtering, adjusting the pH to neutral, and sterilizing to obtain the corn straw alkali pretreatment stock solution.

[0074] The invention also provides a method for synthesizing fraxinusin by transforming ferulic acid with brewer's yeast.

[0075] The present invention also provides a method for introducing an exogenous AtCOSY gene module to strengthen the spontaneous reaction (isomerization and lactonization) process and thus increase the yield of the target product.

[0076] The present invention also provides a method for introducing an exogenous AtS8H gene module to enhance hydroxylation and thus increase the yield of a target product.

[0077] The present invention also provides a method for improving the yield of target products by optimizing fermentation conditions.

[0078] The invention also provides a system configuration method for using the hydrolyzate obtained by alkali pretreatment of corn stalks for yeast fermentation.

[0079] The present invention also provides a method for realizing high-value lignin by engineering the brewer's yeast strain.

[0080] The present invention also provides a method for catalyzing the conversion of ferulic acid into fraxetin by heterologously expressing S8H derived from Arabidopsis thaliana and COSY derived from Arabidopsis thaliana in Saccharomyces cerevisiae.

[0081] The present invention also provides a method for determining key enzymes of the pathway by overexpressing 4CL (p-coumarate CoA ligase), F6'H1 (feruloyl CoA 6'-hydroxylase), COSY (coumarin synthase) and S8H (scopoletin 8-hydroxylase).

[0082] The present invention also provides a method for increasing the COSY copy number to strengthen the spontaneous reaction (isomerization and lactonization) process, thereby increasing the yield of fraxetin.

[0083] The present invention also provides a method for increasing the hydroxylation effect by increasing the copy number of S8H, thereby increasing the yield of fraxetin.

[0084] The invention also provides a method for increasing the yield of fraxinusin by optimizing fermentation conditions.

[0085] The invention also provides a method for synthesizing fraxinusin by using the hydrolyzate obtained by alkali pretreatment of corn stalks as a substrate.

[0086] The technical effects of the present invention include: first, the present invention adopts brewer's yeast, which has strong stress resistance and strong tolerance to environmental stresses such as high-concentration ethanol and low pH, can alleviate the problem of substrate and product inhibition, and improve the catalytic efficiency of the enzyme; compared with other chassis microorganisms, brewer's yeast has good biosafety and robustness, relatively mature gene manipulation technology, relatively high metabolic efficiency, and is convenient for the introduction and regulation of heterologous pathways. Compared with most lignin-degrading bacteria, it has better biosafety, is suitable for fermentation production, and can realize diversified fermentation processes;

[0087] Secondly, compared with the published methods for the biosynthesis of quercetin, the present invention introduces two heterologous gene modules, which provide new research targets for the biosynthesis of quercetin. In addition, the use of corn stalks for fermentation reduces production costs, reduces dependence on expensive carbon sources, promotes a circular economy, converts agricultural waste into valuable products (such as biofuels, feed or chemicals), and promotes the recycling of resources.

[0088] Thirdly, the lignin treatment method of the present invention is gentle and easy to operate, corn straw resources are abundant, raw materials are easily available, the fermentation process is sustainable, the cost is low, and it is widely distributed. It can effectively utilize agricultural waste and is more environmentally friendly than some acidic or high-temperature pretreatment methods. It helps to reduce environmental pollution and reduce the ecological burden caused by incineration or stacking treatment. Moreover, fermentation is carried out by adding lignin hydrolyzate to the culture medium, which reduces the complex process of monomer separation, improves the utilization rate of the substrate, reduces intermediate steps, simplifies the process flow, and improves conversion efficiency.

[0089] More importantly, the yield of quercetin obtained by the present invention is the highest yield reported so far.

[0090] In summary, the present invention overcomes the shortcomings of the prior art, realizes the bioconversion of ferulic acid and lignin hydrolysate to quercetin, and provides a feasible strategy for green conversion for the high-value utilization of lignin. BRIEF DESCRIPTION OF THE DRAWINGS

[0091] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art are briefly introduced below.

[0092] Figure 1 The design of biological pathway for the synthesis of quercetin from ferulic acid in Saccharomyces cerevisiae is shown;

[0093] Figure 2 The results show the aesculin production ability of yHBT146, yHBT147 and yHBT148;

[0094] Figure 3 The transformation ability of scopoletin after changing to YPD medium was shown;

[0095] Figure 4 The production capacity of aesculin after changing to YPD medium was shown;

[0096] Figure 5 Shows the validation results of key enzymes in metabolic pathways;

[0097] Figure 6 The results showed the ability of producing fraxin after strengthening key enzymes;

[0098] Figure 7 The OD in the fermentation system after optimizing the fermentation conditions 600 , fraxinusin, and scopolamine;

[0099] Figure 8 The figure shows the changes of ferulic acid in the fermentation system after optimizing the fermentation conditions;

[0100] Fig. 9 The OD in the system during the fermentation process of lignin hydrolysate 600 , fraxinusin, and scopolamine;

[0101] Fig.10 Shows the changes of ferulic acid and p-coumaric acid in the system during the fermentation process of lignin hydrolysate. DETAILED DESCRIPTION

[0102] The present invention discloses an engineered strain of Saccharomyces cerevisiae and its application in the production of quercetin. Those skilled in the art can refer to the content of this article and appropriately improve the process parameters to achieve it. It should be particularly noted that all similar substitutions and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention. The method and application of the present invention have been described through preferred embodiments, and relevant personnel can obviously modify or appropriately change and combine the methods and applications described herein without departing from the content, spirit and scope of the present invention to implement and apply the technology of the present invention.

[0103] The present invention uses the model organism Saccharomyces cerevisiae as the chassis, and constructs a metabolic pathway for converting lignin-derived monomer ferulic acid and synthesizing the natural active product quercetin in a cell factory: (a) COSY and S8H from Arabidopsis thaliana are introduced and the function of AtS8H hydroxylase is verified; (b) two main reactions of hydroxylation and spontaneous enhancement (isomerization and lactonization) are integrated; (c) key genes are found through pathway gene overexpression, multi-copy integration optimizes the rate-limiting step, and fermentation conditions are optimized to increase yield; (d) combined with sodium hydroxide alkaline pretreatment of corn stover, the bioconversion process of lignin to quercetin is completed. This application is helpful to establish the biosynthesis of quercetin and provide new ideas for the high-value utilization of lignin.

[0104] Table 1: Gene codon optimization involved in this application

[0105]

[0106]

[0107] Table 2: Primers involved in this application

[0108]

[0109]

[0110]

[0111] The Saccharomyces cerevisiae strain capable of synthesizing and stably accumulating scopoletin using ferulic acid as a precursor involved in the present application was provided by Yuan Yingjin's research group, and the strain number is SyBE_Sc05020072 (yZCH21). For the specific construction method, refer to Engineering budding yeast for the production of coumarins from lignin (Chen-Hui Zhao et al., Biochemical Engineering Journal, Vol. 160, 2020, 107634, ISSN 1369-703X, https: / / doi.org / 10.1016 / j.bej.2020.107634), and the genotype is: BY4742, HO::his3_T TDH3 -P TDH3 -AtF6′H1-(GGGGS)4-Pc4CL-T CYC1 Among them, Pc4CL is 4CL from Petroselinumcrispum, encoding 4-coumarate-CoA ligase; AtF6′H1 is F6′H1 from Arabidopsisthaliana, encoding feruloyl-CoA 6′-hydroxylase.

[0112] The sequence of ZCH415 involved in this application is:

[0113]

[0114]

[0115]

[0116] The sequence of ZCH416 involved in this application is:

[0117]

[0118]

[0119] This application involves P TDH3 The sequence is:

[0120]

[0121] This application involves P TEF1 The sequence is:

[0122]

[0123]

[0124] This application involves T CYC1 The sequence is:

[0125]

[0126] This application involves T TDH3 The sequence is:

[0127]

[0128] This application involves T PDC1 The sequence is:

[0129]

[0130] Unless otherwise specified, the raw materials, reagents, consumables and instruments involved in the present invention are all common commercial products and can be purchased from the market.

[0131] The present invention will be further described below in conjunction with the embodiments.

[0132] Example 1: Construction and verification of a strain capable of converting scopoletin into afraxin

[0133] The SyBE_Sc05020072 strain, which can stably accumulate scopoletin, was used as the chassis, and AtS8H from Arabidopsis thaliana was expressed by a free plasmid to achieve hydroxylation of scopoletin and convert it into aconitin. The codon-optimized DNA sequence is shown in Table 1, and the primers are shown in Table 2.

[0134] Experimental methods:

[0135] The strain containing gene expression cassettes used in this experiment was previously constructed and preserved by our laboratory. There are three expression cassettes, all of which are single-copy plasmids, namely: pScop-7 (ZCH415_T CYC1 -P TEF1 -TPDC1 )、pScop-38(ZCH415_T TDH3 -P TDH3 -T CYC1 ) and pScop-39(ZCH416_T TDH3 -P TDH3 -T CYC1 pScop-39 was inserted with the AtS8H gene and named pHBT089 (ZCH416_T TDH3 -P TDH3 -AtS8H-T CYC1 ), pScop-38 was inserted with the AtCOSY gene and named pHBT091 (ZCH415_T TDH3 -P TDH3 -AtCOSY-T CYC1 ), pScop-7 was inserted with the AtCOSY gene and named pHBT093 (ZCH415_T CYC1 -P TEF1 -AtCOSY-T PDC1 ), wherein the ZCH415 plasmid contains the nutritional deficiency tag gene LEU2, and the ZCH416 plasmid contains the nutritional deficiency tag gene URA3. The plasmid vector pScop-39 and the pUC57 plasmid containing the gene AtS8H were digested with BsaⅠ, and the linearized vector and gene were recovered by agarose gel, connected by T4 DNA ligase, and heat-activated and transferred to Escherichia coli Trans1-T1 competent cells. Amp resistance was used for screening, and the transformants were initially batch-verified by colony PCR. The strains with correct band verification were inoculated into LB+Amp liquid culture medium for culture, and the plasmids were extracted and sent for sequencing verification. The transformants with correct sequencing results were stored. Finally, the Escherichia coli strain containing the plasmid pHBT089 was obtained.

[0136] Plasmid pHBT089 was transformed into yeast SyBE_Sc05020072 by lithium acetate transformation to obtain strain yHBT137.

[0137] Experimental results:

[0138] The fermentation experiment was carried out in 50 mL of SC fermentation medium at a culture temperature of 30 °C, a rotation speed of 220 rpm, and a fermentation time of 96 h. Scopoletin was added as a substrate at a substrate concentration of 100 mg / L into the fermentation medium. The initial OD of the bacterial solution was 600 =0.2, verifying the ability of strain yHBT137 to transform scopoletin into fraxin. Fermentation verification showed that scopoletin was converted into 9.92 mg / L fraxinin after 96 h of fermentation.

[0139] Example 2: Construction and verification of a strain capable of converting ferulic acid into fraxin

[0140] Using SyBE_Sc05020072 strain that can stably accumulate scopoletin as the chassis, AtS8H and AtCOSY from Arabidopsis thaliana were expressed by free plasmids. AtS8H achieved the hydroxylation process, and AtCOSY enhanced the spontaneous reaction process, thereby converting ferulic acid into quercetin. The codon-optimized DNA sequence is shown in Table 1, and the primers are shown in Table 2.

[0141] Experimental methods:

[0142] Plasmid pHBT091 was constructed according to the method in Example 1 and transferred into yeast SyBE_Sc05020072 to obtain strain yHBT139. Plasmid pHBT089 and pHBT091 were transferred into yeast SyBE_Sc05020072 together to obtain strain yHBT141.

[0143] The fermentation experiment was carried out in 50 mL of SC fermentation medium at a culture temperature of 30 °C, a rotation speed of 220 rpm, and a fermentation time of 96 h. Ferulic acid was added to the fermentation medium as a substrate at a substrate concentration of 100 mg / L. The initial OD of the bacterial solution was 600 =0.2, verifying the ability of strains yHBT137, yHBT139 and yHBT141 to convert ferulic acid into quercetin. After 96h of fermentation, the three strains produced 0.86mg / L, 0.87mg / L and 1.07mg / L quercetin, respectively.

[0144] Example 3: Construction of Saccharomyces cerevisiae strains yHBT146, yHBT147 and yHBT148 for enhanced synthesis of fraxin

[0145] The effects of the selected enzymes in the pathway were confirmed by verification in Examples 1 and 2, so the above genes were integrated. The strain SyBE_Sc05020072 already contains Pc4CL from Petroselinum crispum and AtF6'H1 from Arabidopsis thaliana, which can catalyze ferulic acid to produce scopoletin. On this basis, AtS8H from Arabidopsis thaliana and AtCOSY from Arabidopsis thaliana were further expressed to achieve the construction of the ferulic acid → 6-hydroxyferuloyl-CoA → scopoletin → quercetin pathway ( Figure 1 ). Primers are shown in Table 2.

[0146] Experimental methods:

[0147] Using plasmid vector pScop-7 as a template, circular PCR was performed on it using primers to obtain a linearized vector. Primers were used to perform PCR on pUC57 plasmid containing the gene AtCOSY to obtain an AtCOSY gene with 20 bp homology arms to the linearized vector at both ends. The linearized vector and gene were recovered by agarose gel and assembled by Gibson seamless cloning. Plasmid pHBT093 was constructed with reference to the transformation and verification methods in Example 1.

[0148] Primers SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 21, and SEQ ID NO: 22 were used to extract the genome of yZCH21 as a template, and gene fragments of about 400 bp upstream and downstream of the YORWdelta17 site on the genome (positions 664,594 to 665,460 on chromosome 15 of the Saccharomyces cerevisiae S288C genome of GCA_000146045.2) were used as part of the homology arms for PCR amplification, and named up homo1 and down homo1. Plasmids pHBT 089 and pHBT093 were used as templates to perform PCR amplification of LEU2, AtS8H expression cassettes, and AtCOSY expression cassettes, respectively, to obtain genes with overlap homology arms. All PCR products were recovered by gel and then subjected to overlap extension PCR to obtain the module up homo1-LEU2-P TDH3 -AtS8H-T CYC1 -down homo1、up homo1-LEU2-P TEF1 -AtCOSY-T PDC1 -down homo1 and uphomo1-P TDH3 -AtS8H-T CYC1 -P TEF1 -AtCOSY-T PDC1 -down homo1 gene fragment, the fragment was recovered from agarose gel and transferred into Saccharomyces cerevisiae SyBE_Sc05020072 by acetic acid transformation method, and SC-LEU solid culture medium plates were coated for screening. The transformants were picked and streaked for pure culture, and the yeast genome was extracted. Primers were used for PCR verification and sent for sequencing. The strains with correct sequencing were named yHBT146, yHBT147 and yHBT148.

[0149] Experimental results:

[0150] The fermentation experiment was carried out in 50 mL of SC fermentation medium at a culture temperature of 30 °C, a rotation speed of 220 rpm, and a fermentation time of 96 h. Ferulic acid was added to the fermentation medium as a substrate at a substrate concentration of 100 mg / L. The initial OD of the bacterial solution was 600 =0.2, and the ability of strains yHBT146, yHBT147 and yHBT148 to convert ferulic acid to quercetin was verified under SC-LEU medium. Figure 2 From left to right, the yields of quercetin are 0.58 mg / L, 1.67 mg / L, 1.48 mg / L, and 2.36 mg / L.

[0151] Example 4: Improvement of the yield of esculin by genome-integrated strains in YPD medium

[0152] The genome-integrated strain in Example 3 was fermented for 96 hours using YPD liquid culture medium, which is richer in nutrients. Except for the optimization of the culture medium from SC-LEU to YPD, other conditions and operations remained unchanged, verifying that the fermentation yield of quercetin in the strain with the synthetic pathway integrated into the genome was improved.

[0153] Experimental results:

[0154] The ability of strains yHBT146, yHBT147 and yHBT148 to convert ferulic acid into quercetin was verified by fermentation with ferulic acid as substrate under YPD medium. Figure 3 , Figure 4 shown. Figure 3 From left to right, the yields of quercetin are 3.31 mg / L and 4.38 mg / L, Figure 4 From left to right, the production of quercetin is 1.10 mg / L, 4.56 mg / L, 4.54 mg / L, and 6.24 mg / L.

[0155] Example 5: Construction of a strain with multiple copies of genes encoding enzymes in the fraxin synthesis pathway

[0156] Based on strain yHBT148, the four pathway enzyme genes in the pathway were inserted into the multi-copy plasmid pRS426 to overexpress a single enzyme gene, explore the effect on the synthesis of quercetin, and determine the possible main rate-limiting enzyme of the pathway based on the change in the yield of quercetin. Primers are shown in Table 2.

[0157] Experimental methods:

[0158] The multi-copy plasmid pRS426 was linearized by restriction enzyme digestion using HindⅢ restriction enzyme and recovered by agarose gel. The primers were used to use the yZCH21 genome, plasmid pHBT089, and plasmid pHBT091 as templates, and PCR amplified the four enzyme genes Pc4CL, AtF6'H1, AtS8H, and AtCOSY, and the left and right ends of each contained 20bp homology arms for Gibson assembly with the linearized vector after restriction digestion of pRS426. After recovery from agarose gel, Gibson assembly was performed with the linearized vector of pRS426, and plasmids pHBT105, pHBT106, pHBT107, and pHBT108 were constructed by referring to the transformation and verification method in Example 1.

[0159] Plasmids pHBT105, pHBT106, pHBT107, and pHBT108 were transferred into yeast yHBT148 by lithium acetate transformation method to obtain strains yHBT150, yHBT151, yHBT152, and yHBT153.

[0160] Experimental results:

[0161] The fermentation experiment was carried out in 50 mL of YPD fermentation medium at a temperature of 30 °C, a rotation speed of 220 rpm, and a fermentation time of 96 h. Ferulic acid was added to the fermentation medium as a substrate at a substrate concentration of 100 mg / L. The initial OD of the bacterial solution was 600 = 0.2, determine the key enzymes in the metabolic pathway, the results are as follows Figure 5 shown. Figure 5 From left to right, the production of quercetin is 2.25 mg / L, 2.46 mg / L, 2.51 mg / L, 3.97 mg / L, and 3.36 mg / L.

[0162] Example 6: Construction of Saccharomyces cerevisiae strains yHBT195, yHBT196 and yHBT198 with integrated genomes to enhance expression of key enzymes

[0163] One copy of AtS8H, one copy of AtCOSY, and one copy of AtS8H and AtCOSY were further introduced into the genome of yeast strain yHBT148 to enhance the hydroxylation and methoxy transfer processes in the aesculin biosynthesis pathway. The primers are shown in Table 2.

[0164] Experimental methods:

[0165] Primers SEQ ID NO:31, SEQ ID NO:32, SEQ ID NO:39, and SEQ ID NO:40 were used to extract the genome of yHBT148 as a template, and gene fragments of about 400 bp upstream and downstream of the YERCdelta8 site on the genome (positions 248,763 to 249,664 on chromosome 5 of the Saccharomyces cerevisiae S288C genome of GCA_000146045.2) were used as part of the homology arms for PCR amplification and named up homo2 and down homo2. Plasmids pHBT089 and pHBT093 were used as templates to PCR amplify URA3, AtS8H expression cassette, and AtCOSY expression cassette, respectively. Overlap PCR was performed to obtain uphomo2-URA3-P TDH3 -AtS8H-T CYC1 -down homo2 and up homo2-URA3-P TEF1 -AtCOSY-T PDC1 -downhomo2 gene fragment, transformed into strain yHBT148 by lithium acetate method, screened on SC-LEU-URA plate, and obtained strains yHBT195 and yHBT196 by referring to the method in Example 3. Using primers SEQ ID NO:41, SEQ ID NO:42, SEQ ID NO:47, SEQ ID NO:48 and yHBT195 genome as template, the upstream and downstream gene fragments of about 400bp each of the YOLCdelta1 site (2512 to 3410 of chromosome 15 of the GCA_000146045.2 Saccharomyces cerevisiae S288C genome) were placed in a PCR instrument for PCR reaction, which was used as part of the homology arm and named up homo3 and down homo3. Plasmids pRS413 and pHBT093 were used as templates, respectively, to perform PCR reaction of HIS3 and AtCOSY expression cassettes, and overlap PCR was performed to obtain uphomo3-HIS3-P TEF1 -AtCOSY-T P DC1 -down homo3 gene fragment, transformed into strain yHBT195 by lithium acetate method, screened on SC-LEU-URA-HIS plates, and obtained strain yHBT198 by referring to the method in Example 3.

[0166] Experimental results:

[0167] The ability of strains yHBT195, yHBT196 and yHBT198 to convert ferulic acid into quercetin was verified by fermentation with ferulic acid as substrate under YPD medium. Figure 6shown. Figure 6 From left to right, the production of quercetin is 0.88 mg / L, 6.11 mg / L, 10.87 mg / L, 8.09 mg / L, and 13.01 mg / L.

[0168] Example 7: Optimization of fermentation conditions to enhance the synthesis of quercetin

[0169] The optimal conditions for the synthesis and fermentation of quercetin by Saccharomyces cerevisiae yHBT198 in YPD medium were explored in the early stage. 600 The concentration of 0.5 was used and the culture was carried out in baffled bottles at 28°C and 220 rpm for 96 h.

[0170] Experimental results:

[0171] The conditions of various substances in the fermentation system are as follows: Figure 7 , Figure 8 shown.

[0172] Example 8: Corn stalk pretreatment and hydrolyzate fermentation

[0173] First, the corn stalks were washed and dried, crushed and sieved, and the particles with a particle size between 20 and 80 mesh were collected and the moisture content was measured at room temperature. According to the solid-liquid ratio of straw: sodium hydroxide solution (concentration of 0.28 mol / L) = 1:9, it was added to the metal reactor, oil bathed at 130℃ for 30 minutes, taken out and immersed in an ice bath to cool to room temperature, filtered with gauze, and the black liquor was collected. It was adjusted to pH = 7 with H2SO4 and sterilized at 115℃ for 15 minutes to obtain the alkali pretreatment stock solution (APL), which is the lignin hydrolyzate. Prepare 50mL fermentation system: 5mL APL (ie 0.1×), 20g / L glucose, 20g / L peptone, and 10g / L yeast extract powder. After secondary activation of strain yHBT198, the initial OD of fermentation inoculation was 600 The concentration of the reaction mixture was 0.5, and the culture was carried out at 28°C and 220 rpm for 96 h.

[0174] Experimental results:

[0175] The monomer concentrations in APL after pretreatment were: p-coumaric acid 2.07 g / L, ferulic acid 0.52 g / L. In the initial fermentation system, p-coumaric acid was 234.17 mg / L, and ferulic acid was 61.04 mg / L. The conditions of the substances in the fermentation system are as follows: Fig. 9 , Fig.10 shown.

[0176] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. Application of a gene element combination in the preparation of fraxinusin, the gene element combination comprising a Pc4CL gene derived from Petroselinumcrispum, an AtF6′H1 gene derived from Arabidopsis thaliana, an AtS8H gene derived from Arabidopsis thaliana and an AtCOSY gene derived from Arabidopsis thaliana.

2. An expression vector, characterized in that The gene element combination in the use according to claim 1.

3. An expression vector combination, characterized in that: The gene element combination in the use according to claim 1.

4. The expression vector combination according to claim 3, characterized in that: Comprising expression vector 1, expression vector 2, expression vector 3 and expression vector 4; The expression vector 1 has an expression cassette of the Pc4CL gene; The expression vector 2 has an expression cassette of the AtF6′H1 gene; The expression vector 3 has an expression cassette of the AtS8H gene; The expression vector 4 has an expression cassette of the AtCOSY gene; The promoter of the expression cassette is selected from P TEF1 , P TDH3 ; The terminator of the expression cassette is selected from T CYC1 、T TDH3 、T PDC1 .

5. A genetically engineered bacterium, characterized in that: include: (1) A combination of genetic elements in the use of claim 1; or (2) An expression vector according to claim 2; or (3) An expression vector combination as described in claim 3 or 4.

6. The genetically engineered bacterium according to claim 5, characterized in that The chassis is brewer's yeast.

7. Use of any of the following in the preparation of quercetin: (i) the expression vector according to claim 2; or (ii) the expression vector combination according to claim 3 or 4; or (iii) The genetically engineered bacterium according to claim 5 or 6.

8. A method for preparing frasquercetin, characterized in that: Prepared based on any of the following: (i) the expression vector according to claim 2; or (ii) the expression vector combination according to claim 3 or 4; or (iii) The genetically engineered bacterium according to claim 5 or 6.

9. The preparation method according to claim 8, characterized in that: The method comprises obtaining fraxinusin by fermentation of the genetically engineered bacteria according to claim 5 or 6, wherein the fermentation conditions are: inoculation initial OD 600 is 0.5, the temperature is 28°C, the rotation speed is 220rpm, and the time is 96h.

10. The preparation method according to claim 8, characterized in that: The method comprises obtaining fraxinusin by fermentation with the genetically engineered bacteria according to claim 5 or 6, wherein the fermentation uses corn stalk alkali pretreated stock solution as a fermentation substrate; The preparation method of the corn straw alkali pretreatment stock solution comprises: mixing corn straw particles with a particle size of 20 to 80 meshes with a sodium hydroxide solution at a solid-liquid ratio of 1:9, reacting at 130° C. for 30 minutes, filtering, adjusting the pH to neutral, and sterilizing to obtain the corn straw alkali pretreatment stock solution.